Literature DB >> 33668331

The Angiotensin II Type 2 Receptor, a Target for Protection and Regeneration of the Peripheral Nervous System?

Aurore Danigo1, Amandine Rovini2, Flavien Bessaguet1, Hichem Bouchenaki1, Amandine Bernard1, Franck Sturtz1, Sylvie Bourthoumieu1, Alexis Desmoulière1, Laurent Magy1,3, Claire Demiot1.   

Abstract

Preclinical evidence, accumulated over the past decade, indicates that the angiotensin II type 2 receptor (AT2R) stimulation exerts significant neuroprotective effects in various animal models of neuronal injury, notably in the central nervous system. While the atypical G protein-coupled receptor superfamily nature of AT2R and its related signaling are still under investigation, pharmacological studies have shown that stimulation of AT2R leads to neuritogenesis in vitro and in vivo. In this review, we focus on the potential neuroprotective and neuroregenerative roles of AT2R specifically in the peripheral nervous system (PNS). The first section describes the evidence for AT2R expression in the PNS and highlights current controversies concerning the cellular distribution of the receptor. The second section focuses on AT2R signaling implicated in neuronal survival and in neurite outgrowth. The following sections review the relatively few preclinical studies highlighting the putative neuroprotective and neuroregenerative effects of AT2R stimulation in the context of peripheral neuropathy.

Entities:  

Keywords:  angiotensin II type 2 receptor; neuroprotection; neuroregeneration; pain; peripheral nervous system

Year:  2021        PMID: 33668331     DOI: 10.3390/ph14030175

Source DB:  PubMed          Journal:  Pharmaceuticals (Basel)        ISSN: 1424-8247


  5 in total

Review 1.  The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target.

Authors:  U Muscha Steckelings; Robert E Widdop; Edward D Sturrock; Lizelle Lubbe; Tahir Hussain; Elena Kaschina; Thomas Unger; Anders Hallberg; Robert M Carey; Colin Sumners
Journal:  Pharmacol Rev       Date:  2022-10       Impact factor: 18.923

2.  Renin-Angiotensin-System Inhibitors for the Prevention of Chemotherapy-Induced Peripheral Neuropathy: OncoToxSRA, a Preliminary Cohort Study.

Authors:  Simon Frachet; Aurore Danigo; Marc Labriffe; Flavien Bessaguet; Bianca Quinchard; Nicolas Deny; Kim-Arthur Baffert; Elise Deluche; Franck Sturtz; Claire Demiot; Laurent Magy
Journal:  J Clin Med       Date:  2022-05-23       Impact factor: 4.964

3.  Angiotensin II Induces Differentiation of Human Neuroblastoma Cells by Increasing MAP2 and ROS Levels.

Authors:  Bryan Jael Collazo; Dariana Morales-Vázquez; Jaylene Álvarez-Del Valle; Javier E Sierra-Pagan; Juan Carlos Medina; Jarold Méndez-Álvarez; Yamil Gerena
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2021-06-14       Impact factor: 1.636

4.  Neuroprotective Effect of Ramipril Is Mediated by AT2 in a Mouse MODEL of Paclitaxel-Induced Peripheral Neuropathy.

Authors:  Hichem Bouchenaki; Amandine Bernard; Flavien Bessaguet; Simon Frachet; Laurence Richard; Franck Sturtz; Laurent Magy; Sylvie Bourthoumieu; Claire Demiot; Aurore Danigo
Journal:  Pharmaceutics       Date:  2022-04-12       Impact factor: 6.525

5.  Ramipril Alleviates Oxaliplatin-Induced Acute Pain Syndrome in Mice.

Authors:  Hichem Bouchenaki; Aurore Danigo; Amandine Bernard; Flavien Bessaguet; Laurence Richard; Franck Sturtz; David Balayssac; Laurent Magy; Claire Demiot
Journal:  Front Pharmacol       Date:  2021-07-19       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.